Dejana Braithwaite, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Dejana Braithwaite, PhD

Assistant Professor, Department of Epidemiology and Biostatistics, UCSF

dejana.braithwaite@ucsf.edu

Phone: (415) 514-8019 (voice)
Box 0560, UCSF
San Francisco, CA 94143-0560

View on UCSF Profiles

Cancer Center Membership

Program Member » Breast Oncology» Cancer Control

Education

1994 University of London, England, German Literature
1998, London Guildhall University, UK, BSc, Psychology/Psychobiology
1999, University College London, UK, MSc, Health Psychology
2004, Cambridge University, Institute of Public Health, UK, PhD, Epidemiology/Behavioral Science
2007, UCSF Breast Cancer Center, Fellowship, Breast Cancer Epidemiology


Professional Experience

  • 2004-2007
    Postdoctoral Fellow, UCSF Helen Diller Family Comprehensive Cancer Center
  • 2007-present
    Assistant Professor, Department of Epidemiology and Biostatistics, University of California, San Francisco, CA

Honors & Awards

  • 2000-04
    Predoctoral Fellowship Award, Cancer Research UK (United Kingdom)
  • 2003
    Scholar in Training Award, American Association for Cancer Research
  • 2007
    Cancer Prevention Research Fellowship from the Prevent Cancer Foundation/American Society for Preventive Oncology
  • 2009
    UCSF Breast Cancer SPORE (Specialized Program of Research Excellence), Developmental Award
  • 2009
    Hellman Family Foundation Award for Early Career Faculty at UCSF
  • 2010
    Best Poster Award, UCSF Breast Oncology Program

Selected Publications

  1. Hubbard RA, O'Meara ES, Henderson LM, Hill D, Braithwaite D, Haas JS, Lee CI, Sprague BL, Alford-Teaster J, Tosteson AN, Wernli KJ, Onega T. Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med. 2016 May 31; 89:169-177.
    View on PubMed
  2. Swede H, Sarwar A, Magge A, Braithwaite D, Cook LS, Gregorio DI, Jones BA, R Hoag J, Gonsalves L, L Salner A, Zarfos K, Andemariam B, Stevens RG, G Dugan A, Pensa M, A Brockmeyer J. Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis. Cancer Causes Control. 2016 May; 27(5):627-36.
    View on PubMed
  3. Braithwaite D, Demb J, Henderson LM. Optimal breast cancer screening strategies for older women: current perspectives. Clin Interv Aging. 2016; 11:111-25.
    View on PubMed
  4. Braithwaite D, Walter LC, Izano M, Kerlikowske K. Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses. J Gen Intern Med. 2016 May; 31(5):561-72.
    View on PubMed
  5. Izano M, Wei EK, Tai C, Swede H, Gregorich S, Harris TB, Klepin H, Satterfield S, Murphy R, Newman AB, Rubin SM, Braithwaite D. Chronic Inflammation and Risk of Colorectal and Other Obesity-Related Cancers: The Health, Aging, and Body Composition Study. Int J Cancer. 2015 Sep 28.
    View on PubMed
  6. Henderson LM, O'Meara ES, Braithwaite D, Onega T. Performance of digital screening mammography among older women in the United States. Cancer. 2015 May 1; 121(9):1379-86.
    View on PubMed
  7. Izano M, Satariano WA, Hiatt RA, Braithwaite D. Smoking and mortality after breast cancer diagnosis: the health and functioning in women study. Cancer Med. 2015 Feb; 4(2):315-24.
    View on PubMed
  8. Epplein M, Bostick RM, Mu L, Ogino S, Braithwaite D, Kanetsky PA. Challenges and Opportunities in International Molecular Cancer Prevention Research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2613-7.
    View on PubMed
  9. Swede H, Andemariam B, Gregorio DI, Jones BA, Braithwaite D, Rohan TE, Stevens RG. Adverse events in cancer patients with sickle cell trait or disease: case reports. Genet Med. 2015 Mar; 17(3):237-41.
    View on PubMed
  10. Hiatt RA, Porco TC, Liu F, Balke K, Balmain A, Barlow J, Braithwaite D, Diez-Roux AV, Kushi LH, Moasser MM, Werb Z, Windham GC, Rehkopf DH. A multilevel model of postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2078-92.
    View on PubMed
  11. Izano M, Satariano WA, Tammemagi MC, Ragland D, Moore DH, Allen E, Naeim A, Sehl ME, Hiatt RA, Kerlikowske K, Sofrygin O, Braithwaite D. Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity? J Geriatr Oncol. 2014 Jul; 5(3):266-75.
    View on PubMed
  12. Izano M, Satariano WA, Hiatt RA, Braithwaite D. The impact of functional limitations on long-term outcomes among African-American and white women with breast cancer: a cohort study. BMJ Open. 2013; 3(10):e003232.
    View on PubMed
  13. O'Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, Geller B, Wernli KJ, Miglioretti DL. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013 Nov 15; 119(22):3959-67.
    View on PubMed
  14. Wernli KJ, Kitahara CM, Tamers SL, Al-Temimi MH, Braithwaite D. Undertaking cancer research in international settings: report from the american society for preventive oncology special interest group on international issues in cancer. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1638-41.
    View on PubMed
  15. Castillo-Trivino T, Braithwaite D, Bacchetti P, Waubant E. Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review. PLoS One. 2013; 8(7):e66308.
    View on PubMed
  16. Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI. J Gen Intern Med. 2013 Nov; 28(11):1454-62.
    View on PubMed
  17. Braithwaite D, Mandelblatt JS, Kerlikowske K. To screen or not to screen older women for breast cancer: a conundrum. Future Oncol. 2013 Jun; 9(6):763-6.
    View on PubMed
  18. Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013 May 13; 173(9):807-16.
    View on PubMed
  19. Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013 Mar 6; 105(5):334-41.
    View on PubMed
  20. Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, Kerlikowske K, Kroenke CH, Sweeney C, Habel L, Castillo A, Weltzien E, Caan B. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33.
    View on PubMed

Go to UCSF Profiles, powered by CTSI